moxonidine has been researched along with Fibrosis in 2 studies
moxonidine: structure given in first source
Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
| Excerpt | Relevance | Reference |
|---|---|---|
| "6 hamsters (6 and 10 months old, with moderate and advanced heart failure, respectively) received moxonidine at 2 concentrations: low (2." | 3.77 | Functional and molecular effects of imidazoline receptor activation in heart failure. ( Abdel Rahman, AA; Aceros, H; Mukaddam-Daher, S; Noiseux, N; Stabile, AM; Stockmeyer, K, 2011) |
| "Regression of left ventricular hypertrophy by moxonidine, a centrally acting sympatholytic imidazoline compound, results from a sustained reduction of DNA synthesis and transient stimulation of DNA fragmentation." | 3.77 | Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt. ( Aceros, H; Cobos-Puc, L; Farah, G; Mukaddam-Daher, S; Noiseux, N; Stabile, AM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stabile, AM | 2 |
| Aceros, H | 2 |
| Stockmeyer, K | 1 |
| Abdel Rahman, AA | 1 |
| Noiseux, N | 2 |
| Mukaddam-Daher, S | 2 |
| Farah, G | 1 |
| Cobos-Puc, L | 1 |
2 other studies available for moxonidine and Fibrosis
| Article | Year |
|---|---|
Functional and molecular effects of imidazoline receptor activation in heart failure.
Topics: Animals; Apoptosis; Blotting, Western; Collagen; Cricetinae; Cytokines; Disease Models, Animal; Dose | 2011 |
Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cell Death; Cell Survival; Collagen; Cytokines; Ec | 2011 |